Purvalanol B
CAS: 212844-54-7
Ref. 3D-MIA84454
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
- 2-Chloro-4-[(2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-isopropyl-9H-purin-6-yl)amino]benzoic acid
- 2-Chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]benzoic acid
- Benzoic acid, 2-chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]-
- Ng 95
Purvalanol B is a kinase inhibitor that targets the apoptosis pathway. Its mechanism of action is to inhibit the production of proteins that are involved in the apoptosis pathway, such as bcl-2 protein. Purvalanol B has been shown to inhibit cancer cells by blocking the nuclear DNA response element, which inhibits transcription and replication of cancerous cells. It also inhibits the production of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α). This drug also works by inhibiting inhibitors of apoptosis proteins, such as bcl-2 and bax.
Chemical properties
Technical inquiry about: 3D-MIA84454 Purvalanol B
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
